Merge Healthcare, Milwaukee, and Durham, NC-based Cato Research Ltd, announced an agreement for Merge to provide Cato with its proprietary etrials EDC solution through Merge’s technology transfer program. The EDC solution will provide Cato with additional technology for clinical trials management.

Having Merge’s technology transfer agreement allows Cato to use etrials to build and deploy custom clinical trial studies. In addition, etrials is built on a software as a service (SaaS) platform, allowing it to be licensed on a subscription or study basis. As a result, Cato will now be able to customize clinical trials software for its research customers.

Allen Cato, M.D., Ph.D., and CEO of Cato said in a joint press announcement, “The etrials technology has been consistent and intuitive, and the Merge team has been quick to help us use it successfully. Adding the etrials EDC platform in a technology transfer model will enable our company to efficiently build and deliver solutions to help our customers run cost-effective clinical studies.”

Visit Merge or Cato for more information.


(Source: Press Release)